Venetoclax (with Dr. Kayleigh Marx)
OncoPharm
00:00
Exploring the Origins and Development of Venetoclax
This chapter explores the history and development of venetoclax, a drug approved for chronic lymphocytic leukemia and acute myeloid leukemia in 2016. It highlights the early studies, dosing strategies, and the complexity involved in the creation of targeted cancer therapies.
Transcript
Play full episode
